Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 12Radiation Injuries 3Glioma 3Glioblastoma 2Cognitive Dysfunction 2Astrocytoma 2Stroke 1Pituitary Neoplasms 1Parkinson Disease 1Oligodendroglioma 1Neurofibromatosis 1 1Neoplasm Metastasis 1Meningioma 1Medulloblastoma 1Infratentorial Neoplasms 1Fatigue 1

Interventions

Temozolomide 115Radiotherapy 63Magnetic Resonance Spectroscopy 30Carboplatin 30Bevacizumab 30Carmustine 28Filgrastim 23Surgical Procedures, Operative 22Irinotecan 22Radiation 18Lomustine 17Vincristine 15Etoposide 15Specimen Handling 13Peripheral Blood Stem Cell Transplantation 13O(6)-benzylguanine 13Radiotherapy, Intensity-Modulated 12Procarbazine 11Erlotinib Hydrochloride 11Cyclophosphamide 11Chemotherapy, Adjuvant 11sargramostim 10Thiotepa 10Cisplatin 10Flucytosine 9Everolimus 9antineoplaston AS 2-1 8antineoplaston A10 8Granulocyte Colony-Stimulating Factor 8Vorinostat 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Astrocytoma × Neuropsychological Tests × CNS × Clear all
NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed
63 enrolled
CNS

Astrocytoma, Oligodendroglioma

NCT01711580 2015-05-12

Re-irradiation of High Grade Gliomas: a Quality of Life Study

Maastricht Radiation Oncology

Withdrawn
CNS

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡